- Trials with a EudraCT protocol (83)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
83 result(s) found for: Social services.
Displaying page 5 of 5.
EudraCT Number: 2008-002102-19 | Sponsor Protocol Number: VEG108844 | Start Date*: 2008-11-24 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||
Full Title: Study VEG108844, a Study of Pazopanib versus Sunitinib in the Treatment of Subjects with Locally Advanced and/or Metastatic Renal Cell Carcinoma | |||||||||||||
Medical condition: Locally Advanced and/or Metastatic Renal Cell Carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) GB (Completed) ES (Completed) SE (Completed) NL (Completed) IT (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004385-17 | Sponsor Protocol Number: MEA115921 | Start Date*: 2013-11-22 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||||||||||||||||||||||||||||||||
Full Title: A Double-blind, Randomised, Placebo-controlled Study to Investigate the Efficacy and Safety of Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis in Subjects Receiving St... | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: Treatment of Eosinophilic Granulomatosis with Polyangiitis in Subjects Receiving Standard of Care Therapy. | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: BE (Completed) DE (Completed) GB (Completed) IT (Completed) ES (Completed) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-000366-11 | Sponsor Protocol Number: ENGOT-Ov41/GEICO69-O/ANITA | Start Date*: 2018-10-31 | |||||||||||
Sponsor Name:Grupo Español de Investigación en Cáncer de Ovario (GEICO) | |||||||||||||
Full Title: A phase III randomized, double-blinded trial of platinum-based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ov... | |||||||||||||
Medical condition: Recurrent ovarian, tubal or peritoneal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Restarted) FR (Completed) DE (Completed) BE (Completed) IT (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
